The Smart Biopsy Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Smart Biopsy Devices Global Market Report 2024 showed a positive growth trend in recent years. It was valued at $2.85 billion in 2024 and is expected to increase to $3.04 billion in 2025, implying a compound annual growth rate (CAGR) of 6.4%.
The Smart Biopsy Devices Global Market is expected to grow to a market size of $4.05 billion in 2029. This growth is forecasted to occur at a compound annual growth rate (CAGR) of 7.5%.
Download Your Free Sample of the 2025 Smart Biopsy Devices Market Report and Uncover Key Trends Now!The key drivers in the smart biopsy devices market are:
• Expansion and growth in personalized medicine
• Advancements in imaging modalities within medical devices
• Increase in biopsies conducted for biomarker analysis
• New competitive entries into the market and improved data connectivity.
The smart biopsy devices market covered in this report is segmented –
1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
The key trends in the smart biopsy devices market are:
• The trend towards robot-assisted biopsies is emerging.
• The use of AI-driven assistance in biopsies is becoming increasingly popular.
• Development of wireless biopsy tools is a new trend in the market.
• The use of portable and handheld devices, along with real-time guidance systems, is shaping the future of the market.
The major players in the smart biopsy devices market are:
• Cardinal Health Inc
North America was the largest region in the smart biopsy devices market in 2024